Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.0001 USD 0.00(0%)
Last update at 2026-11-19T21:00:00Z
VOLUME
200000
Market Cap
0.38M

Momentum Score

…

CuraScientific Corp. engages in the manufacturing, distribution, and sale of cannabis products under the JW Brands and Chad Enterprises brand names. It offers cannabidiol, kava, and kratom. The company was formerly known as Boon Industries, Inc. and changed its name to CuraScientific Corp. in April 2023. CuraScientific Corp. was incorporated in 2020 and is based in Coachella, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

CuraScientific Corp. (CSTF.US) is quoted on the OTC Pink market and public filings and disclosures provide few verifiable details about its operations, products, or target markets. Because available information is sparse, material long-term growth drivers cannot be reliably identified, though some investors may be attracted by typical microcap upside if the company clarifies strategy and delivers regular, audited reporting.

The most important investment risks are lack of transparent, up-to-date disclosures, very low liquidity, high potential for share dilution, and general financial and regulatory uncertainty common to OTC Pink listings.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
1.05M
Revenue Per Share
0.01
Gross Profit TTM
-0.78M
Debt / Equity
-0.04
ROE
-
Net Debt
2.64M
ROCE
4.18%
Diluted EPS TTM
-0.18

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax 33.70M -5.27M -5.87M -4.86M -
Net income 33.70M -5.27M -5.87M -4.86M -
Selling general administrative 2.10M 1.79M 4.22M 2.19M -
Gross profit 0.48M 0.02M 0.06M 0.04M -
Reconciled depreciation 0.02M 0.62M 0.61M 0.39M -
Ebit - -3.97M -6.80M -2.71M -0.02M
Ebitda - -3.35M -6.19M -2.33M -
Depreciation and amortization - 0.62M 0.61M 0.39M -
Operating income -2.89M -2.38M -4.78M -2.53M -
Other operating expenses - 2.41M 4.86M 2.59M 0.38M
Interest expense 0.20M 1.22M 1.16M 0.37M -
Tax provision 0.00M 0.00M 0.00M 0.00M -
Net interest income -0.20M -1.22M -1.16M -0.37M -
Income tax expense - -0.37M -0.87M 0.19M -
Total revenue 1.05M 0.03M 0.09M 0.06M -
Total operating expenses 3.95M 2.40M 4.83M 2.57M -
Cost of revenue 0.58M 0.01M 0.03M 0.02M -
Total other income expense net 36.79M -1.67M 0.06M -1.96M -
Net income from continuing ops 33.70M -5.27M -5.87M -4.86M -
Net income applicable to common shares - -5.27M -5.87M -4.86M -0.47M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 1.55M 2.24M 2.73M - 0.12M
Intangible assets 1.43M 2.02M 2.62M - -
Other current assets 0.04M 0.08M 0.00M - -
Total liab 71.06M 71.63M 199.43M - 0.12M
Total stockholder equity -69.51M -69.39M -196.70M - 0.00M
Other current liab 67.84M 70.45M 198.86M 0.43M -
Common stock 0.33M 0.04M 0.00M - -
Capital stock 0.33M 0.04M 0.00M - -
Retained earnings -16.45M -11.19M -5.32M -0.45M 0.00M
Other liab 0.25M - - - -
Cash 0.00M 0.02M 0.01M - 0.00M
Total current liabilities 70.81M 71.63M 199.43M 0.57M -
Current deferred revenue 0.19M 0.14M 0.06M - -
Net debt 2.64M 1.04M 0.43M - 0.11M
Short term debt 2.64M 1.06M 0.44M - -
Short long term debt 2.64M 1.06M 0.44M - -
Short long term debt total 2.64M 1.06M 0.44M - 0.12M
Other stockholder equity -53.39M -58.24M -191.39M -0.01M -
Property plant equipment 0.09M 0.09M 0.09M 0.10M -
Total current assets 0.04M 0.13M 0.01M 0.00M 0.00M
Net tangible assets -71.83M -71.66M -199.32M -0.47M -
Net receivables 0.00M 0.02M 0.00M - -
Inventory 0.00M 0.01M 0.01M - -
Accounts payable 0.33M 0.11M 0.14M - -
Non current assets total 1.51M 2.11M 2.72M - 0.12M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -0.02M -0.01M -0.01M 0.00M -
Change to liabilities - 0.20M -0.02M 0.14M 0.00M
Total cashflows from investing activities - -0.01M -0.01M -0.01M -0.01M
Net borrowings - 0.25M 0.61M 0.12M 0.26M
Total cash from financing activities 0.37M 0.25M 0.58M 0.44M 0.26M
Change to operating activities - 0.48M 0.47M 0.03M 0.01M
Net income 33.70M -5.27M -5.87M -4.86M -0.47M
Change in cash 0.04M -0.02M 0.02M 0.00M -0.00M
Begin period cash flow 0.00M 0.02M 0.01M 0.00M -
End period cash flow 0.04M 0.00M 0.02M 0.01M 0.00M
Total cash from operating activities -0.30M -0.25M -0.55M -0.43M -0.27M
Depreciation 0.02M 0.62M 0.61M 0.39M 0.01M
Change to inventory 0.07M 0.01M -0.00M -0.01M -0.01M
Change to account receivables 0.02M 0.04M -0.02M -0.02M -0.02M
Other cashflows from financing activities - -0.01M 0.58M 0.44M 0.31M
Change to netincome - 3.06M 3.77M 3.56M 0.00M
Capital expenditures 0.15M 0.01M 0.01M 0.01M 0.01M
Change in working capital 0.54M 0.72M 0.43M 0.16M -
Stock based compensation 0.63M 0.47M 3.30M 1.60M -
Other non cash items -39.67M 3.20M 0.97M 2.29M -
Free cash flow -0.45M -0.27M -0.56M -0.43M -

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CSTF
CuraScientific Corp.
-
-%
0.00 - - 0.36 - 1.02 0.03
MKKGY
Merck KGaA ADR
-0.68
2.09%
31.83 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
163.45 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
0.38
1.77%
21.79 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
43.05 - 10.66 0.01 1.16 2.94 23.11

Profile*

CuraScientific Corp.

CuraScientific Corp. engages in the manufacturing, distribution, and sale of cannabis products under the JW Brands and Chad Enterprises brand names. It offers cannabidiol, kava, and kratom. The company was formerly known as Boon Industries, Inc. and changed its name to CuraScientific Corp. in April 2023. CuraScientific Corp. was incorporated in 2020 and is based in Coachella, California.

51544 Cesar Chavez Street, Coachella, CA, United States, 92236

909 435 1642

2

Name Title Year Born
Mr. Justin Gonzalez Chief Operating Officer 1981
Mr. Johann Loewen Chief Revenue Officer 1976
Mr. Samuel L. Berry CEO, President, Secretary & Interim Chairman of the Board 1979

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…